Cargando…

Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study

BACKGROUND: Increased plasma Urotensin II (UII) levels have been found in adults with renal diseases. Studies in children are scarce. The objective of the study is to estimate plasma UII levels in subjects with chronic kidney disease (CKD) stages 3 to 5 and renal transplant recipients (RTR). In addi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garoufi, Anastasia, Drapanioti, Styliani, Marmarinos, Antonios, Askiti, Varvara, Mitsioni, Andromachi J., Mila, Maria, Grigoriadou, Georgia, Georgakopoulos, Dimitrios, Stefanidis, Constantinos J., Gourgiotis, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374664/ https://www.ncbi.nlm.nih.gov/pubmed/28359257 http://dx.doi.org/10.1186/s12882-017-0530-9

Ejemplares similares

Plasma Brain Natriuretic Peptide Levels in Children with Chronic Kidney Disease and Renal Transplant Recipients: A Single Center Study
por: Garoufi, Anastasia, et al.
Publicado: (2022)

Plant sterols–enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia: a prospective study
por: Garoufi, Anastasia, et al.
Publicado: (2014)

miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment
por: Piatopoulou, Despina, et al.
Publicado: (2017)

Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index
por: Garoufi, Anastasia, et al.
Publicado: (2021)

Insulin-Like Growth Factor (IGF)-I and Insulin in Normal and Growth-Restricted Mother/Infant Pairs
por: Malamitsi-Puchner, Ariadne, et al.
Publicado: (2007)

Overexpression of the GR Riborepressor LncRNA GAS5 Results in Poor Treatment Response and Early Relapse in Childhood B-ALL
por: Xagorari, Marieta, et al.
Publicado: (2021)

Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines
por: Geyik, Sırma, et al.
Publicado: (2016)

Validation of Serum Biomarkers Derived from Proteomic Analysis for the Early Screening of Preeclampsia
por: Kolialexi, Aggeliki, et al.
Publicado: (2015)

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

LONG TERM EFFECTS OF SARS-COV-2 INFECTION ON CHILDREN'S VASCULATURE
por: Karaviti, Dareilena, et al.
Publicado: (2023)

Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome?
por: Babińska, Magdalena, et al.
Publicado: (2012)

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells
por: Park, Sung Lyea, et al.
Publicado: (2013)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

The burden of subclinical cardiovascular disease in children and young adults with chronic kidney disease and on dialysis
por: Lalayiannis, Alexander D, et al.
Publicado: (2021)

Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study
por: Xie, Huijian, et al.
Publicado: (2020)

Plasma levels of urotensin II are increased in patients with three-vessel coronary artery disease and left ventricular dysfunction
por: Heringlake, M, et al.
Publicado: (2003)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
por: Portnoy, Alison, et al.
Publicado: (2013)

Plasma urotensin II and neurokinin B levels in acute myocardial infarction and stable coronary artery disease
por: Akkoyun, Dursun Çayan, et al.
Publicado: (2016)

Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis
por: Vartzelis, George, et al.
Publicado: (2019)

The Urotensin System Is Up-Regulated in the Pre-Hypertensive Spontaneously Hypertensive Rat
por: Forty, Ellen J., et al.
Publicado: (2013)

Psychosocial and cognitive function in children with nephrotic syndrome: association with disease and treatment variables
por: Manti, Panagiota, et al.
Publicado: (2013)

Urotensin-II System in Genetic Control of Blood Pressure and Renal Function
por: Debiec, Radoslaw, et al.
Publicado: (2013)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

A closer look at the role of urotensin II in the metabolic syndrome
por: Barrette, Pierre-Olivier, et al.
Publicado: (2012)

Urotensin II in Invertebrates: From Structure to Function in Aplysia californica
por: Romanova, Elena V., et al.
Publicado: (2012)

Irisin levels are associated with urotensin II levels in diabetic patients
por: He, Wan-Yu, et al.
Publicado: (2015)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
por: Simunovic, Marko, et al.
Publicado: (2022)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
por: Ogawa, Akiko, et al.
Publicado: (2023)

Perinatal Plasma Monocyte Chemotactic Protein-1 Concentrations in Intrauterine Growth Restriction
por: Briana, Despina D., et al.
Publicado: (2007)

Cerebral hemorrhagic infarction as the initial manifestation of deep venous thrombosis in a child with patent foramen ovale
por: Panagopoulos, Dimitrios, et al.
Publicado: (2018)

Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat
por: Eyre, Heather J., et al.
Publicado: (2019)

Urotensin II levels in patients with chronic kidney disease and kidney transplants
por: Hursitoglu, Mehmet, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tqh28j12hlgmqvesevrenltdi6